Landscapes / Companies
Epizyme, Inc. not checked
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 3 in all
Trials
1 active
18 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Approved | 13 Feb 2027Phase 3 trial completes | |||
| Next date | 13 Feb 2027 · Phase 3 trial completes | ||||
| Also tested for | Relapsed/Refractory Follicular Lymphoma, Follicular Lymphoma and 1 more | ||||
| Open drug page | |||||
About
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021